Top Markets
Coin of the day
Qlife Holding AB (publ) Qlife Holding AB (publ)

Qlife Holding AB (publ)

QLIFE
Rankning i aktier #36577
Operating as a medical technology firm, Qlife Holding AB (publ) specializes in... Operating as a medical technology firm, Qlife Holding AB (publ) specializes in the production and distribution of in-vitro diagnostic instruments and their associated chemical reagents. Their flagship offering is the Egoo.Health Platform, a comprehensive system comprising a measuring device, single-use test capsules, and integrated software. This innovative platform facilitates the detection of various biomarkers or viral agents, with each capsule tailored for a distinct diagnostic purpose. The range of supported biomarkers encompasses C-reactive protein for home-based monitoring, Phenylalanine (PHE) vital for managing Phenylketonuria (PKU) in patients, and a multiplex test designed to identify Sars-CoV-2 and Influenza, aiding in the detection of viral and bacterial infections. Established in 2019, Qlife's operations are headquartered in Helsingborg, Sweden.
Aktiekurs
$0.20529272
Senast synkroniserad: 2026-08-14
Marknadsvärde
$2.54M
Förändring (1 dag)
0.11%
Förändring (1 år)
-49.29%
Land
SE
Handel Qlife Holding AB (publ) (QLIFE)

Kategori

Utdelningsavkastning för Qlife Holding AB (publ) (QLIFE)
Utdelningsavkastningen (TTM) för Qlife Holding AB (publ) (aktiesymbol: QLIFE) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.00%
Historik för utdelningsavkastning för Qlife Holding AB (publ) (QLIFE) från 2026 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
Inte tillräckligt med data för de angivna datumen.
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter